Buonagurio D A, Coleman J W, Patibandla S A, Prabhakar B S, Tatem J M
Wyeth-Lederle Vaccines and Pediatrics, Pearl River, New York 10965, USA.
J Clin Microbiol. 1999 Feb;37(2):283-9. doi: 10.1128/JCM.37.2.283-289.1999.
A multiplex reverse transcription-PCR method was optimized to monitor the duration of excretion of Sabin poliovirus strains in stools of vaccinees following administration of the first dose of the trivalent oral vaccine. The assay detected approximately 1 50% tissue culture infective dose of each poliovirus serotype spiked into cell culture media. Although PCR inhibitors were frequently encountered in the stool specimens, a 1:20 dilution of the extracted RNA was sufficient to obtain a positive PCR result. Analysis of 195 stool specimens collected from 26 vaccinees showed that poliovirus types 1, 2, and 3 were identified more frequently by PCR than by tissue culture isolation. The percentages of specimens positive by PCR for poliovirus types 1, 2, and 3 were 67.2, 82.6, and 53.8, respectively. In contrast, the culture method identified types 1, 2, and 3 virus in 55.4, 64.1, and 27.7% of the samples, respectively. Poliovirus type 2 excretion was detected by PCR in practically all of the oral poliovirus vaccine recipients for 4 to 8 weeks following vaccination. In contrast, excretion of type 1 and 3 viruses was more variable, with a range of 1 to 8 weeks. Shedding of type 3 virus ceased in approximately 70% of vaccinees within a week after immunization. In addition to an enhanced sensitivity for the detection of poliovirus, this PCR method permits the direct characterization of virus in stool specimens without further passage in culture, which may select for genetic variants that may not accurately reflect the virus composition in the original specimen.
优化了一种多重逆转录 - 聚合酶链反应方法,以监测接种首剂三价口服疫苗后疫苗接种者粪便中萨宾脊髓灰质炎病毒株的排泄持续时间。该检测方法能检测到添加到细胞培养基中的每种脊髓灰质炎病毒血清型约1 50%组织培养感染剂量。尽管在粪便标本中经常遇到聚合酶链反应抑制剂,但提取的RNA 1:20稀释足以获得阳性聚合酶链反应结果。对从26名疫苗接种者收集的195份粪便标本进行分析表明,与组织培养分离法相比,聚合酶链反应更频繁地鉴定出1型、2型和3型脊髓灰质炎病毒。1型、2型和3型脊髓灰质炎病毒聚合酶链反应阳性标本的百分比分别为67.2%、82.6%和53.8%。相比之下,培养法分别在55.4%、64.1%和27.7%的样本中鉴定出1型、2型和3型病毒。在接种疫苗后的4至8周内,几乎所有口服脊髓灰质炎疫苗接种者的粪便中都通过聚合酶链反应检测到2型脊髓灰质炎病毒的排泄。相比之下,1型和3型病毒的排泄情况更不稳定,持续时间为1至8周。约70%的疫苗接种者在免疫后一周内停止排出3型病毒。除了提高检测脊髓灰质炎病毒的灵敏度外,这种聚合酶链反应方法还允许直接鉴定粪便标本中的病毒,而无需在培养中进一步传代,因为传代可能会选择出不能准确反映原始标本中病毒组成的基因变体。